TX HB46

Expands qualifying medical conditions for low-THC cannabis prescriptions to include chronic pain, traumatic brain injury, Crohn's disease/inflammatory bowel disease, and terminal illness/hospice care patients, adding to existing conditions like epilepsy, cancer, PTSD, and autism

Redefines "low-THC cannabis" from one percent THC by weight to not more than 10 milligrams of tetrahydrocannabinols per dosage unit, with packages/containers limited to a total of one gram of THC

Increases the number of licensed dispensing organizations from the current number to 15, with at least 9 new licenses to be issued by December 1, 2025, and at least 3 additional licenses by April 1, 2026

Allows dispensing organizations to operate satellite storage locations across public health regions without additional licenses, requiring department approval and 180-day review timeline for applications

Permits pulmonary inhalation via aerosol or vaporizer as an administration method (distinct from smoking) when a physician determines medical necessity, and allows prescriptions for up to 90-day supplies with up to four refills